Ombitasvir, Paritaprevir, Ritonavir

Technivie

12.5 MG + 75 MG + 50 MG TabletCanadaCancelledAuthorised 24 Nov 2015

This page is kept for reference and is not offered to search engines.

In other countries

The same active substances on other registers, the same brand first.

TechnivieUnited States · 12.5MG; 75MG; 50MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · tablet · AbbvieSame brand
Viekirax 12,5 mg/ 75 mg/ 50 mg comprimidos recubiertos con peliculaSpain · 75,0 mg + 12,5 mg + 50 mg · comprimido recubierto con película · Abbvie Deutschland Gmbh & Co. KgSame form
VIEKIRAX film-coated tabletSaudi Arabia · Fournier Laboratories Ireland LimitedSame form
ViekiraxEuropean Union · AbbVie Deutschland GmbH & Co. KGSame substance
ViekiraxRomania · 12.5 mg+ 75 mg + 50 mg · compr. film. · Abbvie Deutschland GMBH & Co. UKSame substance

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Ombitasvir, Paritaprevir, Ritonavir

Technivie

12.5 MG + 75 MG + 50 MG TabletCanadaCancelledAuthorised 24 Nov 2015

Open in the registerAsk Osler about it

This page is kept for reference and is not offered to search engines.

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

VIEKIRAX 12.5mg/75mg/50mgRomania · 12.5mg/75mg/50mg · compr. film. · Abbvie LTD

Documents

The official texts, at the regulator.

Register entryHealth Canada

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Health Canada, Canada

Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.

Licence: Open Government Licence Canada · Added 13 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substances: Ombitasvir, Paritaprevir, Ritonavir
Strength: 12.5 MG + 75 MG + 50 MG
Dosage form: Tablet
Route: Oral
Register: Canada (Health Canada)
Status: Cancelled
Status in the register: Cancelled Post Market
Authorised: 24 Nov 2015
Registration: DIN 02447711
Marketing authorisation holder: Abbvie Corporation
ATC code: J05AP53
Group: Anti-infectives for systemic use
Supply: PRESCRIPTION